COMMUNIQUÉS West-GlobeNewswire

-
Biophytis Announces Three Oral and One Poster Presentations at the 2019 International Conference on Frailty and Sarcopenia Research
18/02/2019 -
Medtronic Announces Preliminary PRODIGY Results: a Global Study to Identify Patients at High Risk for Opioid-Induced Respiratory Compromise
18/02/2019 -
REVA Announces Trading Halt
17/02/2019 -
Updated Results from Phase 1 Study of Telaglenastat (CB-839) to be Presented at 2019 ASCO Genitourinary Cancer Symposium
16/02/2019 -
Acarix adapts pathway for German reimbursement - Submission of new dossier by the end of February 2019
15/02/2019 -
Kiadis Pharma Notice of Extraordinary General Meeting of Shareholders
15/02/2019 -
Sienna Announces February Dividend
15/02/2019 -
HEXO Corp. enters into $65 million bank debt facility
15/02/2019 -
HEXO Corp conclut une facilité de crédit bancaire de 65 millions de dollars
15/02/2019 -
ORYZON Reports Financial Results and Corporate Update for the 4th Quarter and Year Ended December 31, 2018
15/02/2019 -
Olainfarm Starts the Year With 40% Sales Increase
15/02/2019 -
CTD Announces Appointment of Sharon H. Hrynkow, PhD as Chief Scientific Officer
15/02/2019 -
Cruzani Returns to QSR Mission
15/02/2019 -
Griffin Health launches its frameless SRS program using C-RAD Catalyst HD with cBrain software
15/02/2019 -
Denali Therapeutics Announces First Patient Dosed in Phase 1b Study of DNL747 for Alzheimer’s Disease
15/02/2019 -
Obalon Schedules Fourth Quarter and Year End 2018 Financial Results Conference Call for February 22, 2019 at 8:30 a.m. Eastern Time
15/02/2019 -
Generex Biotechnology Announces Investor Conference Call Agenda; Tuesday, February 26, at 11:00 A.M. Eastern
15/02/2019 -
Dragon Jade Enters MOU for Stake in Connaissance Holdings
15/02/2019 -
Xbrane Biopharma AB informs about presentations where the company participates on February 19
15/02/2019
Pages